Suzhou Zelgen Biopharmaceuticals Co. Ltd Financials

Market Capitalization CN¥17.49 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	-60.61
Forward PE	-53.28
Price to Sales TTM	CN¥35.81
Price to Book MRQ	CN¥13.42
Enterprise to Revenue	32.63
Enterprise to EBITDA	-59.50

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	-35.70%
Operating Margin	-25.92%
Return on Assets TTM	-6.50%
Return on Equity TTM	-12.48%

Income Statement

Revenue TTM	CN¥488,451,168
Revenue per Share TTM	CN¥1.85
Quarterly Revenue Growth	130.70%
Gross Profit TTM	CN¥451,453,312
EBITDA	CN¥-267,866,256
Net Income to Common TTM	CN¥-174,396,320
Diluted EPS TTM	CN¥-0.66
Quarterly Earnings Growth YoY	130.67%

Balance Sheet

Total Cash MRQ	CN¥2,203,613,184
Total Cash per Share MRQ	CN¥8.33
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	70.85
Current Ratio MRQ	1.95
Book Value per Share MRQ	CN¥4.92

Cash Flow

Operating Cash Flow TTM	CN¥63,115,880
Levered Free Cash Flow TTM	CN¥-160,690,320

688266 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	264,708,000
Float Shares	148,085,700
Avg 10 Volume	1,775,791
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	39.95%
% Held by Institutions	23.94%

Stock Price Summary

Beta	0.64
Fifty Two Week Low	CN¥33.20
Fifty Two Week High	CN¥79.99
Fifty Two Week Change	33.75%
Day 50 MA	CN¥64.46
Day 200 MA	CN¥58.63

Dividends and Splits

Forward Annual Dividend Rate	CN¥
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	CN¥0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date